Dietary supplementation of beta-glucan-rich molasses yeast powder on antibody response to swine fever virus and hematology of starter–grower pigs

This research investigated the impact of dietary beta-glucan-rich molasses yeast powder (MYP) supplementation on the antibody response to swine fever virus (Titer) and hematology of starter–grower pig. Sixteen cross pigs (30 kg body weight) were equally split into four groups; each group with four r...

Full description

Saved in:
Bibliographic Details
Main Authors: Pitukpol Pornanek, Chirasak Phoemchalard
Other Authors: Rajamangala University of Technology Isan
Format: Article
Published: 2022
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/75536
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
Description
Summary:This research investigated the impact of dietary beta-glucan-rich molasses yeast powder (MYP) supplementation on the antibody response to swine fever virus (Titer) and hematology of starter–grower pig. Sixteen cross pigs (30 kg body weight) were equally split into four groups; each group with four replicates and fed four dietary treatments that consisted of basal diets (control) and the basal diets added with 2.5, 5.0, and 7.5% MYP. Feed and water were consumed ad libitum for 44 days. Feed intake (FI), MYP intake (MYPI), beta-glucan intake (BGI), and Mannan-oligosaccharide intake (MOSI) were recorded daily. Titer was evaluated after 15 (Titer15) and 30 (Titer30) days after vaccination, while hematology was analyzed at the end of the experiment. The results indicated that it was unchangeable for ADFI (P > 0.05). No impacts were observed on hematological variables and Titer15 in MYP fed pigs (P > 0.05). However, supplementation with 7.5% MYP increased platelet count (PC) and Titer30 (P < 0.01), but decreased hematocrit (Hct) (P < 0.05). Titer 30 and titer 15 were linked to MYPI, BGI, and MOSI (P < 0.05). Based on the study, feeding starter–grower pigs diets supplemented with 7.5% MYP might enhance the antibody response to swine fever virus 30 days after vaccination, and it has a potential role in the application in prevention of swine fever virus disease.